A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd., a subsidiary of Chinese pharmaceutical firm Sinopharm, in Beijing Dec. 25, 2020. (Xinhua/Zhang Yuwei)
Chinese COVID-19 vaccine developers – Sinovac, Sinopharm and CanSinoBio – have submitted application to join the WHO’s COVAX plan: Chinese FM
